• About Us
  • Contact Us
  • Home
  • Photo Box
  • Privacy Policy
Wednesday, January 27, 2021
Kashmir Bylines
  • Home
  • News
  • Politics
  • Literature
  • In Depth
  • Photo Box
  • Opinion
  • World
  • Login
  • Register
No Result
View All Result
  • Home
  • News
  • Politics
  • Literature
  • In Depth
  • Photo Box
  • Opinion
  • World
No Result
View All Result
Kashmir Bylines
No Result
View All Result
Home Health

Cleared in UK, Bahrain, Pfizer seeks emergency use of its COVID-19 vaccine in India

News Desk by News Desk
December 6, 2020 | 12:25 pm
in Health
Cleared in UK, Bahrain, Pfizer seeks emergency use of its COVID-19 vaccine in India

Pfizer India has become the first pharmaceutical firm to seek an emergency use authorisation for its Covid-19 vaccine in the country after its parent company secured such clearance in the UK and Bahrain.

In its application submitted to the Drugs Controller General of India (DCGI), the firm has sought permission to import the vaccine for sale and distribution in the country, besides waiver of clinical trials on Indian population in accordance with the special provisions under the New Drugs and Clinical Trials Rules, 2019, official sources told the news agency.

“Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization (EUA) for its COVID-19 vaccine in India,” a source said.

“The firm has submitted the EUA application in Form CT-18 for grant of permission to import and market Pfizer-BioNTech’s COVID-19 mRNA vaccine BNT162b2 in the country,” the source said, citing the application.

V K Paul, who chairs the high-level National Expert Group on Vaccine Administration, had earlier spelt out India’s strategy with respect to candidates like Pfizer and Moderna which have shown positive results in Phase III abroad but are not being tested here.

“We know that doses of this vaccine (Pfizer) will not be available in huge quantities… If this vaccine candidate has to come, and if we require it, we are preparing ourselves… we have parallel plans,” Paul had said.

For the vaccine to be considered for use here, the Indian subsidiary of Pfizer will have to approach the regulator and share the data it has submitted to the UK regulator.

“They can then ask for an approval and, accordingly, the regulator will take a decision,” an official had told The Indian Express.

The UK on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19, with the UK regulator Medicines and Healthcare products Regulatory Agency (MHRA) granting a temporary authorisation for its emergency use.

The British regulator said the jab, which claims to offer up to 95 per cent protection against COVID-19, is safe for roll-out.

Bahrain on Friday also announced that it has granted a EUA for the two-dose vaccine made by Pfizer and its German partner BioNTech. The pharma company has already applied to the US FDA seeking EUA for the vaccine.

The extremely low temperature of minus 70 degrees Celsius required for storing the vaccine poses a big challenge for its delivery in a country like India, especially in its smaller towns and rural areas where maintaining such cold chain facilities would be very difficult, top government officials have said.

When contacted, Pfizer said it remains committed to engaging with the Government of India and explore opportunities to make this vaccine available for use in the country.

“During this pandemic phase, Pfizer will supply this vaccine only through government contracts based on agreements with respective government authorities and following regulatory authorisation or approval,” the global pharma major said in a statement.

Five vaccines are in advanced phases of clinical trials in India with the Serum Institute of India conducting the phase-3 trial of the Oxford-Astrazeneca COVID-19 vaccine, while the indigenously developed vaccine by Bharat Biotech in collaboration with ICMR has already started the phase-3 clinical trial.

Drug firm Zydus Cadila has received the approval from the DCGI to start the phase-3 clinical trials of the indigenously-developed anti-coronavirus vaccine.

Dr Reddy’s Laboratories and the Russian Direct Investment Fund (RDIF) have announced that they commenced adaptive phase 2 and 3 clinical trials for COVID-19 vaccine Sputnik V in India, Also, Biological E. Ltd has started early phase 1 and 2 human trials of its Covid-19 vaccine candidate.

With inputs from PTI and The Indian Express

ADVERTISEMENT
ShareTweetSendShare
ADVERTISEMENT

Related Posts

Locals allege harassment as surveillance, frisking intensify ahead of Indian R-Day in Kashmir

Locals allege harassment as surveillance, frisking intensify ahead of Indian R-Day in Kashmir

by News Desk
January 23, 21
0

Srinagar: A multi-layer security arrangement including a ground and aerial survey has been put in...

109 fresh COVID-19 cases reported in J&K, tally reaches 123647

109 fresh COVID-19 cases reported in J&K, tally reaches 123647

by News Desk
January 20, 21
0

Srinagar: Sixteen travelers among 109 fresh COVID-19 cases were reported in Jammu and Kashmir in...

Govt asks employees to attend January 26 functions, warns against ‘disobedience’

Govt asks employees to attend January 26 functions, warns against ‘disobedience’

by News Desk
January 20, 21
0

Srinagar: The Jammu and Kashmir government has asked its workforce to attend the main official...

First batch of COVID-19 vaccines reaches Srinagar

First batch of COVID-19 vaccines reaches Srinagar

by News Desk
January 13, 21
0

Srinagar: The first batch of COVID-19 vaccines reached Srinagar on Wednesday afternoon with officials saying...

Union Home Ministry orders deployment of 49 more CRPF battalions in J&K

Kashmir reports first two cases of new UK COVID-19 strain

by News Desk
January 9, 21
0

Srinagar: After a decline in the number of COVID-19 cases, two cases of new UK...

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

LATEST NEWS

Kulgam militant attack: One among injured soldiers succumbs

Militant attack in South Kashmir, two army personnel injured

Youth shot at in Soura Srinagar last month succumbs

Handwara Massacre: The Sequel to Gawkadal Massacre

Locals allege harassment as surveillance, frisking intensify ahead of Indian R-Day in Kashmir

Minor girl found hanging at home in Kupwara

94 fresh COVID-19 cases in J&K, no new case in 11 districts

Jammu-Srinagar National highway to remain closed tomorrow: Authorities

Local Muslims walk on foot amid snow carrying dead body of Pandit stuck in Shopian

‘Infiltration tunnel’ detected along International border in Hiranagar sector

Kashmir Bylines is now on Telegram. Click here to Join.
ADVERTISEMENT
Facebook Twitter Instagram Telegram Youtube

About us

Kashmir Bylines is an online media venture based in Kashmir. We aim to bring you news and views about politics, history, education and culture from the valley and beyond. We aspire to create an alternative space in media by making daily news a running commentary while carrying detailed views, analysis, opinions and reviews as well. With readers’ preferences shifting from print to digital modes, we opt to make your choice our own and be with you on your journey of awareness.

More Info

  • About Us
  • Contact Us

© 2020-2021 Kashmir Bylines

No Result
View All Result
  • Home
  • News
  • Politics
  • Literature
  • In Depth
  • Photo Box
  • Opinion
  • World

© 2020-2021 Kashmir Bylines

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In